EUVIMEDEUVIMED entdecken
Crossref

Implementation of a myasthenia gravis drug‐disease interaction clinical decision support tool reduces prescribing of h igh‐risk medications

Megan E Barra iD, Andrew J Webb, Russel J Roberts, Marjorie Ross, Robert Hallisey, Paul Szumita, Amanda C Guidon iD

Muscle & Nerve · 2023

DOI: 10.1002/mus.27790 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Muscle & Nerve, 2023. Verfasst von Megan E Barra und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Medical Order Entry Systems, Decision Support Systems, Clinical, Myasthenia Gravis. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction/Aims High‐risk medication exposure is a modifiable risk factor for myasthenic exacerbation and crisis. We evaluated whether real‐time electronic clinical decision support (CDS) was effective in reducing the rate of prescribing potentially high‐risk medications to avoid or use with caution in patients with myasthenia gravis.

Methods

An expert panel reviewed the available drug‐disease pairings and associated severity levels to activate the alerts for CDS. All unique alerts activated in both inpatient and outpatient contexts were analyzed over a two‐year period. Clinical context, alert severity, medication class, and alert action were collected. The primary outcome was alert override rate. Secondary outcomes included the percentage of unique medication exposures avoided and predictors of alert override.

Results

During the analysis period, 2817 unique alerts fired, representing 830 distinct patient‐medication exposures for 577 unique patients. The overall alert override rate was 85% (80.3% for inpatient alerts and 95.8% for outpatient alerts). Of unique medication‐patient exposures, 19% were avoided because of the alert. Assigned alert severity of “contraindicated” were less likely to be overridden (odds ratio [OR] 0.42, 95% confidence interval [CI] 0.32–0.56), as well as alerts activated during evening staffing (OR 0.69, 95% CI 0.55–0.87).

Discussion

Implementation of a myasthenia gravis drug‐disease interaction alert reduced overall patient exposure to potentially harmful medications by approximately 19%. Future optimization includes enhanced provider and pharmacist education. Further refinement of alert logic criteria to optimize medication risk reduction and reduce alert fatigue is warranted to support clinicians in prescribing and reduce electronic health record time burden.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medical Order Entry SystemsDecision Support Systems, ClinicalMyasthenia GravisHumansMedication ErrorsElectronic Health Records

Stichwörter der Autor:innen

adverse eventsdrug interactionsmedical order entry systemsmyasthenia gravissafety

Autor:innen und Institutionen

  • Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Neurology, Newton Wellesley Hospital, Newton Lower Falls, Massachusetts, USA.
  • Department of Pharmacy, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA.

ORCID-Profile: Megan E Barra, Amanda C Guidon

Zitieren

APA

Barra, M. E., Webb, A. J., Roberts, R. J., Ross, M., Hallisey, R., Szumita, P., & Guidon, A. C. (2023). Implementation of a myasthenia gravis drug‐disease interaction clinical decision support tool reduces prescribing of h igh‐risk medications. Muscle & Nerve. https://doi.org/10.1002/mus.27790

Vancouver

Barra ME, Webb AJ, Roberts RJ, Ross M, Hallisey R, Szumita P, et al. Implementation of a myasthenia gravis drug‐disease interaction clinical decision support tool reduces prescribing of h igh‐risk medications. Muscle & Nerve. 2023. doi:10.1002/mus.27790

BibTeX
@article{Barra2023,
  author = {Barra, Megan E and Webb, Andrew J and Roberts, Russel J and Ross, Marjorie and Hallisey, Robert and Szumita, Paul and Guidon, Amanda C},
  title = {Implementation of a myasthenia gravis drug‐disease interaction clinical decision support tool reduces prescribing of h igh‐risk medications},
  journal = {Muscle & Nerve},
  year = {2023},
  doi = {10.1002/mus.27790}
}
Kostenlos starten →